6
Oct
2026
Wacker Chemie AG
Exhibitor at CPHI Milan 2026 stand 1H4, Excipients&Fine Chemicals
About Us
Categories
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:5
-
Employees:5000+
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 1H4, Excipients&Fine Chemicals
Products Featured at CPHI Milan 2026
-
Product CAVAMAX® W6 Pharma
CAVAMAX® W6 PHARMA is pharmaceutical grade alpha-cyclodextrin from Wacker Chemie AG.
With 6 glucose units, it has the smallest cavity of the parent cyclodextrins. It is useful for solubilizing, stabilizing or delivering small molecules.
-
Product CAVAMAX® W7 Pharma
Wacker offers a wide range of products which includes . It is pharmaceutical grade beta-cyclodextrin from Wacker Chemie AG. CAVAMAX® W7 with seven glucose units has the mid-size cavity of the parent cyclodextrins. It is useful for stabilizing, solubilizing or delivering intermediate size molecules, e.g. me... -
Product CAVAMAX® W8 Pharma Cyclodextrins
Wacker offers a wide range of products which includes . It is pharmaceutical grade gamma-cyclodextrin from Wacker Chemie AG. CAVAMAX® W8 with 8 glucose units has the largest cavity of the parent cyclodextrins and is the most water soluble. It is useful for solubilizing, stabilizing or delivering larger mol... -
Product CAVASOL® W8 HP Pharma Cyclodextrins
Wacker offers a wide range of products which includes . It is a pharmaceutical grade hydroxypropyl-gamma-cyclodextrin from Wacker Chemie AG. It is a highly soluble gamma-cyclodextrin derivative, when concentrated solutions are needed. Applications: Formulations for pharmaceuticals. Contact us for more info... -
Product CAVASOL® W7 HP Pharma Cyclodextrins
Wacker offers a wide range of products which includes . It is pharmaceutical grade hydroxypropyl-beta-cyclodextrin from Wacker Chemie AG. Applications: Formulations for pharmaceuticals. Packaging: Units of 10 kg. Physical state: solid - powder. Colour: white. Odour: odourless. Applications: Formulations fo...
